US20080114261A1 - System and method for the automatic detection of the expiratory flow limitation - Google Patents
System and method for the automatic detection of the expiratory flow limitation Download PDFInfo
- Publication number
- US20080114261A1 US20080114261A1 US12/013,626 US1362608A US2008114261A1 US 20080114261 A1 US20080114261 A1 US 20080114261A1 US 1362608 A US1362608 A US 1362608A US 2008114261 A1 US2008114261 A1 US 2008114261A1
- Authority
- US
- United States
- Prior art keywords
- subject
- automatic detection
- expiratory flow
- flow limitation
- accordance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 44
- 238000001514 detection method Methods 0.000 title claims abstract description 24
- 230000000241 respiratory effect Effects 0.000 claims abstract description 23
- 230000029058 respiratory gaseous exchange Effects 0.000 claims description 30
- 230000002269 spontaneous effect Effects 0.000 claims description 16
- 210000002345 respiratory system Anatomy 0.000 claims description 12
- 230000003434 inspiratory effect Effects 0.000 claims description 9
- 238000004458 analytical method Methods 0.000 claims description 6
- 230000003595 spectral effect Effects 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 18
- 210000004072 lung Anatomy 0.000 description 8
- 238000005259 measurement Methods 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 235000019988 mead Nutrition 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 239000003570 air Substances 0.000 description 5
- 238000004364 calculation method Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000013459 approach Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000005399 mechanical ventilation Methods 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 238000005070 sampling Methods 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 230000000414 obstructive effect Effects 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 210000000779 thoracic wall Anatomy 0.000 description 2
- 238000009423 ventilation Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000007717 exclusion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000001595 flow curve Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 229940050561 matrix product Drugs 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- NZWOPGCLSHLLPA-UHFFFAOYSA-N methacholine Chemical compound C[N+](C)(C)CC(C)OC(C)=O NZWOPGCLSHLLPA-UHFFFAOYSA-N 0.000 description 1
- 229960002329 methacholine Drugs 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003387 muscular Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000011422 pharmacological therapy Methods 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000036544 posture Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 210000003019 respiratory muscle Anatomy 0.000 description 1
- 238000013125 spirometry Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/08—Measuring devices for evaluating the respiratory organs
- A61B5/085—Measuring impedance of respiratory organs or lung elasticity
Definitions
- FIG. 4 a shows a graph where a maximum flow-volume curve overlays a flow-volume curve obtained from spontaneous breathing
- the electrical signals related to the measurements of flow and pressure are connected to the circuits 20 of analogical-digital (A/D) and digital-analogical (D/A) conversion.
- the circuits 20 controlled by a microprocessor 23 , provide an output signal that is applied in succession to a low pass filter 21 , to a power amplifier 22 and then to a loudspeaker 12 .
- the flow and pressure signals are digitised at a proper sampling frequency, paying attention to avoid aliasing phenomenon by means of apposite filters.
- the effect of the decomposition of the signals with the band-pass filters is to obtain couples of signals with a better signal/noise ratio than that of the starting couple of signals.
- the spectrum of the original pressure and flow signals will also contain, in addition to the stimulus frequencies and to the background noise, all the harmonics of such frequencies and the spurious frequencies generated by the crosstalk effect. If N stimulus frequencies are chosen according to a pattern that excludes the possibility that a frequency is a whole multiple of any other component of the signal, it is possible to prevent the harmonies from falling on the N frequencies chosen; opting instead for a pattern of the type non-sum non-difference of order 2 or greater, the spurious frequencies generated by the crosstalk are prevented from failing on the N frequencies of the stimulus.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Physiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
The present invention refers to a system and a method for the automatic detection of the expiratory flow limitation of a subject. In an embodiment thereof the system for the automatic detection of expiratory flow limitation of a subject comprises: means for determining the respiratory impedance of said subject composes of an imaginary component and, eventually, of a real path or, at least, means to apply a forcing signal with one or more spectral components to the airway opening of a subject combined with means to measure time courses of pressure and flow at the airway opening; means for determining at least one index linked to said respiratory impedance or pressure and flow time courses; means for indicating the positioning of said at least one index in relation to a preset threshold value.
Description
- The present invention refers to a system and a method for the automatic detection of the expiratory flow limitation in patients.
- The human respiratory system is characterised by the phenomenon called expiratory flow limitation, that is by the fact that during expiration the flow of gases expelled depends on the expiratory pressures only up to a certain threshold value, beyond which the flow cannot be increased even if expiratory pressures are increased. The threshold value is function of the lung volume (being higher at high volumes then decreasing with the reduction of the lung volume) and is, in healthy subjects, considerably higher than the maximum flows obtained during spontaneous breathing. The difference between maximum expiratory flow and expiratory flow during spontaneous breathing measured at the same lung volume constitutes the reserve of expiratory flow. Such reserve is used in situations such as physical exercise, in which the metabolic requirements and, consequently) the lung ventilation increase. The resulting increase of the tidal volume and of the respiratory frequency therefore requires the increase of both inspiratory and expiratory flows, Several obstructive pathologies of the respiratory system (chronic obstructive pulmonary disease or COPD, asthma, . . . ) modify the mechanical properties of airways and lung parenchyma, notably reducing the reserve values of expiratory flow until it is annulled. In addition, the reduction can be so marked that it forces the patient to breathe at higher lung volumes than usual to make use of the dependence of the maximal flow on lung volume and to obtain the expiratory flows needed for a correct gas exchange. This phenomenon is knows as “dynamic hyperinflation”. Breathing at higher lung volumes, however, means both using the inspiratory muscles in a geometric condition which is unfavourable to them (reduced muscular length and consequent reduction of the capacity to produce force) and having the thoracic wall expanding to volumes at which it is more stiff. All these effects combine to determine a significant increase in the respiratory work, excessively tiring the respiratory muscles and thus limiting the capacity of the patient to carry out even simple physical activity. To know whether a patient is flow-limited during spontaneous breathing is therefore of fundamental importance for the diagnosis and definition of the rehabilitation and pharmacological therapy, as well as the assessment of their effectiveness.
- As of today the methods used for identifying whether a subject is limited in the expiratory flow can be divided into two main categories: those based on the measurement of the oesophageal pressure and those that do not use this measurement, The former are currently considered the only reliable ones, but they require a latex balloon connected to a catheter-pressure transducer system for measuring the oesophageal pressure to be inserted into the lower third of the oesophagus. Esophageal pressure is considered an excellent estimate of the pleural pressure and therefore it allows the estimation of alveolar pressure. From the relationship between alveolar pressure and flow at the airway opening it is possible to assess the presence of expiratory flow limitation during quiet breathing in different ways (for example studying the so called “isovolume pressure flow curves” or analysing Mead and Whittenberger graphs). Unfortunately this procedure is invasive and it is not tolerated by a large percentage of subjects, in addition it requires a lot of time (both for the insertion of the balloon and for the patient to adapt to it) and it may significantly alter the breathing pattern of the subject.
- The methods belonging to the second category are based on the determination of the flow-volume curves carried out in body plethysmograph and on the application of negative pressure to the airways during the expiratory phase or on abdominal compression. However these methods are characterised by both theoretical and practical limitations and therefore they are usually considered not very reliable and, in the first case, require the collaboration of the subject.
- A study by M. Vassiliou, R. Peslin, C. Saunier, C. Duvivier, entitled “Expiratory flow limitation during mechanical ventilation detected by the forced oscillation method”, European respiratory Journal, 1996, suggests a method for determining expiratory flow limitations based on the forced oscillations technique able of indicating the possible presence of expiratory flow limitation induced by bronco constrictor drugs (methacholine) in rabbits submitted to mechanical ventilation. In this study it can be observed that expiratory flow limitation is responsible for systematic variations of the imaginary part (Xrs) of the total respiratory input impedance (Zrs) in mechanical models of a single collapsible airway and in mechanically ventilated rabbits. The Applicant believes that the analyses described in the article mentioned above were carried out under extremely critical and particular conditions, that is on mechanically ventilated animals in which the limitation of the expiratory flow was induced pharmacologically and on mechanical models that simulate the behaviour of only one single airway and that therefore they do not reproduce real conditions occurring in humans with obstructive diseases (hundreds of thousands of airways placed in series and in parallel in the tracheal-bronchial tree constricted in a very heterogeneous pattern).
- In view of the state of the technique, the object of the present invention is to provide a method and a system for assessing automatically in a non-invasive manner whether the expiratory flow limitation is present or not in a subject, without requiring subject collaboration and continuously in time.
- In accordance with the present invention, said object is achieved by means of a system for the automatic detection of expiratory flow limitation of a subject comprising: means for determining the respiratory impedance of said subject composed of a real component and a imaginary component; means for determining at least one index linked to said respiratory impedance; means for indicating the positioning of said at least one index in relation to a preset threshold value.
- In accordance with the present invention, said object is also achieved by means of a Method for the automatic detection of the expiratory flow limitation of a subject comprising the phases of: determining the respiratory impedance of said subject composed of a real component arid an imaginary component; determining at least one index linked to said respiratory impedance; indicating the positioning of said at least one index in relation to a preset threshold value.
- Thanks to the present invention it is possible to study patients in an absolutely non-invasive manner, without, requiring their collaboration, under very different conditions, (during spontaneous breathing at rest, exercise, mechanical ventilation and various respiratory manoeuvres such as vital forced and slow capacities, maximum voluntary ventilation, etc.). In addition, it allows to study subjects in various postures (erect, sitting, supine, prone).
- In addition, it permits automatically, without any intervention, to detect the presence of expiratory flow limitations.
- The characteristics and advantages of the present invention will appear evident from the following detailed description of an embodiment thereof, illustrated as non-limiting example in the enclosed drawings, in which:
-
FIG. 1 shows schematically a system for the automatic detection of the expiratory flow limitation of a patient in accordance with the present invention; -
FIGS. 2 a, 2 b and 2 c show the graphics of the volume, the flow, the impedance and the oesophageal pressure of a healthy patient, respectively of a patient with chronic obstructive pulmonary disease (COPD) but not flow-limited and a patient with COPD and flow-limited during spontaneous breathing; -
FIG. 3 shows the sensitivity graphics with a continuous line, and specificity with a dotted line, in function of the value adopted as threshold for the various indices in accordance with the present invention; -
FIG. 4 a shows a graph where a maximum flow-volume curve overlays a flow-volume curve obtained from spontaneous breathing; -
FIG. 4 b shows the progress of Xrs and of the flow F over the time. - In
FIG. 1 the airways of a patient are connected by means of amouthpiece 10 to aduct 11 that is connected to aloudspeaker 12. Asensor device 13 for measuring the flow of air inside and asensor device 14 for measuring the air pressure is applied to theduct 11. Atube 15 at high inertia and anaspirator 16 are also applied to the duct. - The electrical signals related to the measurements of flow and pressure, supplied respectively by the
13 and 14, are connected to thedevices circuits 20 of analogical-digital (A/D) and digital-analogical (D/A) conversion. Thecircuits 20, controlled by amicroprocessor 23, provide an output signal that is applied in succession to alow pass filter 21, to apower amplifier 22 and then to aloudspeaker 12. - The determination of the time course of the respiratory impedance during the spontaneous breathing is carried out by applying a pressure signal to the airway opening of the patient consisting of the summation of one or more sinusoids among which at least one has a frequency no higher than 15 Hz. For example 4 sinusoids at frequencies of 2.5 Hz, 5.5 Hz, 9.5 Hz and 17.5 Hz.
- Said pressure signal must preferably have an amplitude between 1-4 cmH2O peak-peak (with the pressure generator connected to a resistive load of 2 cmH2O/L*s); in any case the amplitude of the stimulus signal should not exceed 5 cmH2O to avoid distortions due to the non-linearity of the respiratory system. The pressure signal, generated in the example in
FIG. 1 by a loudspeaker, can be generated by cylinder-piston systems or by suitable servo-controlled valves. For simplicity in the rest of the description we shall refer to the pressure generator consisting of a loudspeaker, even though this choice is not bound to the functioning of the method herein presented as other devices can be used for this purpose (piston pumps, servo-controlled valves, etc.). The pressure waves generated are applied to the airway opening of of the subject by means of aduct 11 in which theflow measuring devices 13 andpressure measuring devices 14 are housed. By airways opening we intend mouth, nose, tracheostomy, etc. Thus pressure and flow are measured, preferably near the entrance of the airways (if a long connection tube is used between the flow and pressure sensors and the subject the measurements must be corrected for mechanical properties of the tube). To enable the subject to breathe spontaneously during the measurement, atube 15 connects the output of the generator of pressure waves with the outside environment. This tube is sized and shaped so as to offer a high impedance to high frequencies generated by the loud-speaker, while at the low frequencies of the spontaneous breathing the impedance must result very low (better if less than 1-2 cmH2O/L/*s for signals of frequency lower than 5 Hz). The large dimensions of this tube (length about lm and diameter about 3-4 cm) introduce considerable dead space, such as not to allow the subject to breathe ambient air. To reduce this dead space, an aspirator 16 (or a compressor) can be used which is able of producing a flow of about 0.2-0.4 l/s (independent mom the oscillating pressure) that permits the expulsion of the gases expired by the subject and, thus, the exchange of the air contained in the tube. In alternative to thelong tube 15 other systems with a similar function can be used, including a simple resistance of 2-3 cmH2O/L*s connected between the generator and the flow measuring device to the atmosphere. - The flow and pressure signals are digitised at a proper sampling frequency, paying attention to avoid aliasing phenomenon by means of apposite filters.
- The Applicant, from the analysis of the variations of Xrs during a single respiration has observed that during spontaneous breathing the flow-listed patients presented considerable reductions in the reactance values measured in the expiratory phase. In addition, similar reductions were also discovered in healthy subjects during maximum forced expirations and, thus, in flow-limitation condition. The explanation of such phenomenon should be as follows. During the expiratory flow-limitation there are points of the airways distributed in the tracheo-bronchial tree (called choke points) in which the speed of propagation of the pressure wave becomes equal to that of the expired air. In these conditions eventual variations of pressure applied to the two ends of the tree (alveoli and airways opening) cannot exceed the choke points, and thus the flow no longer results to be dependent on the difference of pressure applied. The pressure oscillations applied at the opening of the airways with the above-described techniques cannot thus reach the alveoli during the expiratory flow limitation condition.
- The inertance of the respiratory system at the frequencies considered is basically due to the upper airways and, at low frequencies, it assumes a marginal role in the definition of Xrs.
- The compliance of the respiratory system is mainly due to the alveoli, as the compliance of the walls of the airways, additive to the former, results in being far lower, as is also that due to the quantity of air contained in the bronchial tree. The apparent ‘closing’ of the airways at the choke points thus causes the exclusion of the alveolar compliance from the measurement, producing a substantial reduction of the compliance observed, which in this condition is prevalently due to the airways walls. A reduction of the apparent compliance causes an increase of the negative component of Xrs arid, thus, a substantial reduction of it during the expiratory phase if in the presence of flow-limitation.
- Various methods can be used to calculate the input impedances of the respiratory system. That used in accordance with the present invention must be capable of calculating the time courses of the impedance during spontaneous breathing at a frequency of at least 5-10 Hz. The various methods for separating the components of the signal due to spontaneous breathing from those due to the forcing can in particular be based on the cross-correlation, the FFT or the estimation by least squares. These operations are carried out by the
computer 23. In accordance with the present invention a method based on least square is used. - To be able to apply this method the stimulus signal Sstim must be a sinusoid or a sum of N sinusoids of known periods T1, T2, . . . TN
- with the following conditions:
∀Ti<<Tresp e Ti>>Tc - where Tresp is the respiratory period and Tc is the sampling period.
- The calculation proceeds in an iterative manner: each iteration processes a number of pressure samples equal to W and a number of flow samples equal to W. At the k-th iteration the samples from the k-th to the (k+W−1)-th are processed, the result is assigned to the time k+W/2 if W is even, and to the time k+(W−1)/2 should W be odd; the following is carried out under the hypothesis that W is even. The choice of parameter W is not critical, as W samples do not have to contain exactly a period of the stimulus signal. As we shall see further ahead in fact, the theory imposes W≧1+2N, by increasing said parameter minor influence of the noise is obtained but at the same time the faster variations of impedance are lost and the calculation times are lengthened. A good compromise between sensitivity to the noise and to the variations of impedance can be obtained using for W the minimum, number of samples that a whole period of the slowest stimulus component contains.
- Each iteration is composed of 2 steps.
- First of all there is the extraction of the pressure and flow signals of the components due to the respiration and calculation of the coefficients to describe the components due to the stimulus in phasor notation.
- For each signal a linear combination of N frequency sinusoids of frequencies equal to the stimulus frequencies is associated:
- where r(t) represents the noise and Re the real part of a complex number.
- As the signals are at discrete time, we have for the pressure:
- where ωi2π/Ti pulsation of the i-nth component of the stimulus, tj=(j−1)TC time associated to the j-th sample of the W selected.
- Note that the matrix A remains identical for all the iterations.
- Such a system allows a solution to the least square as long as W≧1+2N, and the solution to the least square is given by:
X P=(A T A)−1 A T S P - As a remains identical for all the iterations, it is possible to calculate B=(ATA)−1AT once and reduce the problem to a vector-matrix product: XP=B SP.
- The coefficient a0 represents the component of the signal due to the respiration while the coefficients ai and bi enable the component of the pressure signal due to the stimulus to the i-th frequency to be written in phasor notation.
- The same procedure is applied to the flow signal.
- Thus the impedance is calculated at the various stimulus frequencies and at the time k+W/2 as ratio between the signal phasors:
- where 1=k+W/2 and 1<i<N and Zi is the impedance to the i-nth stimulus frequency.
- Each iteration requires 2(W−1)(1+2N) sums and 2W(1+2N) products between real numbers, and N ratios between complex numbers; therefore this method can be competitive in comparison to other methods in terms of execution speed. This calculation method thus enables us to obtain the time progresses of the impedance at numerous frequencies, with the possibility of freely choosing these frequencies, as long as the second requisite is respected. It is important to point out that this method provides time progresses of the impedance filtered with a moving average filter of amplitude W.
- The possibility of varying the parameter r permits the choice of the most suitable compromise between sensitivity to the noise and passing band of that filter.
- To be able to reduce the impact of the noise on the assessment of the impedance in the case of multifrequency signals with a high number of components (N>3−4) the method proposed above can be modified as follows.
- The pressure and flow signals are decomposed in a component due to the respiration and N components due to the various frequencies of the stimulus by means of a series of numeric Butterworth filters of suitable order (typically of the 4th order). A low-pass filter with cut-off frequency of suitable frequency (1-3 Hz for spontaneous breathing) separates the component due to the respiration, a series of N band-pass filters instead separates the components due to the various stimulus sinusoids. The i-nth band-pass filter has a passing band centred on the i-th frequency of the stimulus signal and an adjustable bandwidth BWi. Using this procedure N couples of pressure and flow signals are obtained from the couple of pressure and flow signals in input, each relating to a certain component of the stimulus. Then we proceed to the calculation of the N impedances relating to the N stimulus frequencies using the method proposed above.
- The method proposed first is thus used in monofrequency modality in is variant, given that the couple of signals that is passed contain only one dominating frequency.
- The effect of the decomposition of the signals with the band-pass filters is to obtain couples of signals with a better signal/noise ratio than that of the starting couple of signals. In fact, as the respiratory system is not linear, the spectrum of the original pressure and flow signals will also contain, in addition to the stimulus frequencies and to the background noise, all the harmonics of such frequencies and the spurious frequencies generated by the crosstalk effect. If N stimulus frequencies are chosen according to a pattern that excludes the possibility that a frequency is a whole multiple of any other component of the signal, it is possible to prevent the harmonies from falling on the N frequencies chosen; opting instead for a pattern of the type non-sum non-difference of
order 2 or greater, the spurious frequencies generated by the crosstalk are prevented from failing on the N frequencies of the stimulus. In this manner, the effect of a narrow band-pass centred on the i-th frequency of stimulus will be to remove the background noise, the other N−1 components caused by the stimulus, all the harmonics and also the spurious frequencies, thus improving the signal/noise ratio. - The parameter BWi must be sized taking into account several considerations. The variation in the time of the impedance at the frequency i-th Zi(t) is reflected in an amplitude modulation of the pressure and flow signals, this means that the spectrum of said signals will contain, besides the frequencies of the stimulus with their harmonics and the background noise, also the components around the stimulus frequencies due to the amplitude modulation of the signals. For the theory of the signals, this surrounding has semiamplitude equal to the maximum modulation frequency, a frequency that here corresponds to the fastest of the spectrum components of the impedance. The parameter BWi sets the width, of the surrounding considered for the i-th frequency, then limits the speed of variation that can be observed of Zi(t,) at BWi/2 Hz. Therefore, also the choice of the parameter BWi constitutes a compromise: keeping the value of BWi low the background noise and the harmonics of the stimulus are eliminated more effectively, but at the same time the fastest variations of Zi(t) are lost; vice versa, a high value of BWi permits even the fastest variations of Zi(t) to be gathered but does not effectively remove the background noise and the harmonics of the stimulus signal.
- Finally it can be noted that the parameters BWi and Wi both have the collateral effect of limiting the maximum speed of variation that can be observed in Zi(t), with the band-pass filter that is applied before the filtering by mobile media actuated by the method. Consequently, it is advisable that the limitation in frequency on Zi(t) comes about by means of the band-pass. This is achieved by choosing BWi and Wi so that the following relation is met:
- where fc is the chosen sampling frequency.
- In
FIGS. 2 a-2 c the graphs are shown, upon varying of the time T, the volume V (1), the flow F (1*sec−1), the impedance Xrs at 5 Hz (cm H2O/1*sec−1) and the oesophageal pressure Pe (cm H2O) of a healthy patient (FIG. 2 a), of a patient with chronic obstructive pulmonary disease (COPD) but not flow-limited (FIG. 2 b), and a patient with chronic obstructive pulmonary disease (COPD), with expiratory flow limitation (FIG. 2 c). - The graphics of the impedance Xrs show two curves, one in a continuous line for the real part and one with a dotted line for the imaginary part.
- In particular take note of the variations of the imaginary part for the patient with chronic obstructive pulmonary disease (COPD), limited flow (
FIG. 2 c). - The use of the difference between the inspiratory and expiratory values of Xrs can thus be used to identify conditions of expiratory flow limitation calculating the values of suitable indices. In particular some different indices are suggested that can be used both singularly and in combination with each other, said indices are: the minimum value of Xrs reached during the expiration (Xrsm), the average value of Xrs during all or part (for example considering the central third part) of the expiratory phase (Xrsem), the difference between the maximum value of s reached during the inspiratory phase and the minimum value of Xrs reached during the expiration (Xrspp), the difference between the average value of Xrs in all or part of the inspiratory phase and the average value of Xrs during all or part of the expiratory phase (Xrsdm), and the regression coefficient (r2) combined with compliance data obtained fitting the impedance data on a resistance-inertance-compliance series model, the latter only if multifrequency forcing signal is used.
- In particular, the latter index is based on the fact that, as already mentioned, during the expiratory flow-limitation (EFL) the measurements of input impedance Zin would reflect only the mechanical properties of the airways between the airway opening and choke points. As already known, it is possible to model expiratory Zin with a simple lumped parameter model consisting of a resistance (R), compliance (C) and inertance (I) in series.
- The equation of motion of the respiratory system obtained considering this model is:
- Where P is the pressure at the airway opening and V is the volume measured at the airway opening (eventually obtained integrating the flow), R is the resistance, C the compliance and I the inertance of the whole respiratory system.
- This model would be valid for healthy subjects, providing e series of a resistant R, an inductor I and a capacitor C, for the whole respiratory system. The model is invalid for COPD patients without flow limitation due to heterogeneity. However, based on our hypothesis, the model would become valid again for COPD with flow limitation but only during expiration and reflecting only the airways between the mouth and choke points. Now, the R and I represent the resistance and inertance of these airways and the C becomes the airway wall compliance which is the only shunt pathway downstream from the choked airways,
- If a multifrequency forcing signal is applied to the subject and the resulting data are used to fit the model, the regression coefficient (r2) or other indices of the performance of how the model fits the data can be used to discriminate the status of subject's airways. In the Table 1 mean±SD of the inspiratory and expiratory values of the parameters estimated on 15 subjects are presented as example. The subjects were aged matched healthy (5 subjects), COPD with no expiratory flow limitation (5 patients) as measured by Mead and Whittenberger method and COPD presenting EFL during quiet breathing (5 patients) accordingly to Mead and Wittenberger method. The C estimated during EFL in COPD were an order of magnitude below the C for healthy subjects, suggesting that in COPD, the C does reflect airway wall compliance rather than parenchymal and chest wall tissues. Moreover, consistently with our hypothesis, the simple series model fits COPD patients data well (see r2 values in Table 1) only during expiration and only if flow limitation is present. This approach then constitutes a potential diagnostic test for identifying the onset of EFL during spontaneous breathing and for estimating the airway wall compliance. The use of the performance index of the model fitting is, in fact, a sensible index of expiratory flow limitation: if it changes to low values to good values passing from expiration to inspiration it means that the subject is flow-limited. Therefore the time course of the performance index of the model fitting can be used as described for Xrs signal to determine indices and thresholds for the detection of EFL. Moreover, this approach has potentially the capability of being implemented without passing through the computation of Zin, but fitting directly pressure and flow data to the model (for example as reported in the article of Lauzon, A. M. and J. H. Bates. Estimation of time-varying respiratory mechanical parameters by recursive least squares. J Appl. Physiol 71, 1159-1165, 1991) and computing the performance index time course This time course can be used similarly to Xrs computing the values of the suggested four indices. For example, to discriminate flow-limited COPD from healthy subjects it is it is possible to analyse changes of the performance index between inspiration and expiration or to consider also the estimated value for the compliance or both. However, this method based on del fitting, differently from the other indices computed on Xrs only, requires that the forcing signal applied to the subject presents more than two frequency components to have reliable estimations.
TABLE 1 EXPIRATION INSPIRATION R C I r2 R C I r2 Control mean 2.89 0.0441 0.0075 0.85 2.58 0.0274 0.0079 0.90 SD 0.10 0.0038 0.0004 0.08 0.18 0.0042 0.0005 0.05 COPD mean 3.56 0.0156 0.0017 0.47 3.01 0.0144 0.0028 0.56 NON SD 0.10 0.0019 0.0006 0.09 0.02 0.0011 0.0005 0.05 EFL COPD mean 3.97 0.0032 0.0060 0.90 5.04 0.0076 −0.0025 0.36 EFL SD 0.08 0.0001 0.0008 0.03 0.12 0.0006 0.0016 0.06 - Once the values of the selected index have been obtained, they are compared with a threshold value, for the mean value during the expiration, that could be equal to 0.77. The exceeding or not of the threshold by the index is used to identify condition of flow-limitation. As an example, the sensitivity values are shown in
FIG. 3 , with a continuous line, defined as the number of respirations in which the flow-limitation is identified and the number of respirations indicated as flow-limited using the Mead and Whittenberger method (which is a graphic method for detecting the presence of expiratory flow limitation, and it is based on the alveolar pressure vs flow at the mouth graph and it is considered a reliable gold-standard for detecting expiatory flow limitation) and specificity, with a dotted line, defined as the number of respirations in which the absence of flow-limitation is identified and the number of respirations indicated as not flow-limited using the Mead and Whittenberger method as a function of the value adopted as threshold for the various indices analysing a population of COPD patients during spontaneous breathing using a stimulus frequency of 5 Hz. In these graphics it can be seen that the indices based on the reactance guarantee zones in which both sensitivity and specificity are equal to 100%. The use of a threshold value within said zone (for example at its centre) allowed us to define a method for detecting the expiratory flow limitation able to provide equal or better performances than those of the Mead and Whittenberger method but with the important advantage of not requiring the use of the oesophagus balloon. Table 2 shows as an example the optimal values obtained to be used as threshold. Optimal reference values can be obtained also considering equations that take into account other parameters such as, the characteristics of the subjects. As it is possible that subjects who are very different from each other (for example a child and an elderly person) give absolute reactance values that are different from each other, and to some measure depend on several specific characteristics of the subject, it could be useful to make the threshold values depend on the type of subject under examination. The same problem is typical of numerous measurements in pneumology, for example each spirometry is accompanied by the aforementioned values for the various indices measured (vital capacity, volume expired in a second, etc.). The threshold values can thus be obtained considering equations that take into account other parameters, such as, the anthropometrical characteristics of the subjects. For this purpose it is possible, starting from the analysis of the values that the various indices assume in the various subjects belonging to a wide and heterogeneous population, to identify the correlations between the parameters that characterise the subject (for example sex, age, weight, race, height, vital capacity, functional residual capacity, etc) and its optimal threshold values for the various indices. From such correlations simple equations can be obtained that predict the optimal threshold values as function of the most significant parameters, so as to improve the specificity and sensitivity of the method.TABLE 2 Excellent Excellent Total interval Excellent interval region threshold Index (cmH2O/l*s−1) (cmH2O/l*s−1) (%) (cmH2O/l*s−1) Xrsem −10.5 + −0.3 −4.7 + −4.2 5.9 −4.5 Xrsm −20.4 + −0.6 −7.6 + −6.3 6.5 −6.9 Xrsdm −0.6 + 9.0 1.9 + 3.4 15.4 2.7 Xrspp 0.2 + 19.7 5.7 + 6.3 3.1 6.0 - It is important to point out that while the indices calculated using the averages can discriminate if a breath is flow-limited or not, the use of the threshold values calculated for Xrsm or Xrspp can also enable the determination of the exact time in which the flow-limitation starts to occur, by carrying out the comparison with the instantaneous value of Xrs. In this case the flow-limitation conditions present can be identified only in part of the expiration (partial flow-limitation) as shown in
FIG. 4 a, where a maximum flow-volume curve overlays a flow-volume curve obtained from spontaneous breathing (left). The arrow points out the moment in which the two curves overlay each other, and thus when the flow-limitation phase starts. Analysing the course in time of Xrs and of the flow F (FIG. 4 b) it can be seen that, when the respiration becomes flow-limited, Xrs descends below the threshold value calculated for the index Xrsm. This approach can also be applied to the study of the flow-volume curves obtained during the execution of forced partial or maximal vital capacity manoeuvres. - In addition, even tough it is necessary to use only one frequency for determining whether a subject is flow-limited or not, the study of the dependence of the values of the various indices with the frequency might give useful information an localization and heterogeneity of the choke points.
Claims (16)
1. System for the automatic detection of expiratory flow limitation of a subject comprising:
means for determining the respiratory impedance of said subject composed of a real component and an imaginary component;
means for determining at least one index linked to said respiratory impedance;
means for indicating the positioning of said at least one index in relation to a preset threshold value.
2. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 1 characterised in that said means for determining at least one index is linked to the imaginary component of said respiratory impedance.
3. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 1 characterised in that said device for determining the respiratory impedance of said subject comprises: a device for generating at least one oscillating pressure signal at a preset frequency;
a duct for applying said at least one oscillating pressure signal to the respiratory system of said subject;
a device for measuring the flow and the pressure inside said duct.
4. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 2 characterised in that said at least one index corresponds to the minimum value of said imaginary component reached during the expiration.
5. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 2 characterised in that said at least one index corresponds to the average value of said imaginary component during all or part of the expiratory phase.
6. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 1 characterised in that said at least one index corresponds to indices computed on the time courses of a performance index of the fitting of the impedance to a prefixed model or of the direct fitting to the flow and pressure measured at the airway opening with the prefixed model.
7. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 2 characterised in that said at least one index corresponds to the difference between the maximum value of said imaginary component reached during the inspiratory phase and the minimum value of said imaginary component reached during the expiration.
8. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 2 characterised in that said at least one index corresponds to the difference between the average value of said imaginary component during all or part of the inspiratory phase and the average value of said imaginary component during all or part of the expiratory phase.
9. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 3 characterised in that said means for determining the respiratory impedance of said subject comprise means for associating to each oscillating pressure signal a linear combination of sinusoids of frequencies equal to the stimulus frequencies;
means for determining the impedance by means of a system at the least square;
means for calculating the impedance at the various stimulus frequencies as ratio of the phasors.
10. System for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 1 characterised in that said analysis comes about during the spontaneous breathing of said patients.
11. Method for the automatic detection of the expiratory flow limitation of a subject comprising the phases of:
determining the respiratory impedance of said subject composed of a real component arid an imaginary component;
determining at least one index linked to said respiratory impedance;
indicating the positioning of said at least one index in relation to a preset threshold value.
12. Method for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 11 characterised in that said phase of determining at least one index is linked to the imaginary component of said respiratory impedance.
13. Method for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 11 characterised in that said phase determining the respiratory impedance of said subject comprises the phases of generating at least one oscillating pressure signal at a preset frequency; applying said at least one oscillating pressure signal to the respiratory system of said subject; measuring the flow and the pressure inside said duct.
14. Method for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 11 characterised in that said at least one index is obtained assessing the difference between the inspiratory and expiratory values of said respiratory impedance of said subject.
15. Method for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 11 characterised in that said preset threshold value is calculated on the basis of an analysis of a population of said subjects.
16. Method for the automatic detection of the expiratory flow limitation of a subject in accordance with claim 11 characterised in that said preset threshold value is calculated on the basis of an equation that takes into account the parameters that characterise a plurality of populations of said subjects.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/013,626 US20080114261A1 (en) | 2002-06-11 | 2008-01-14 | System and method for the automatic detection of the expiratory flow limitation |
| US12/640,880 US8128575B2 (en) | 2002-06-11 | 2009-12-17 | System and method for the automatic detection of the expiratory flow limitation |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2002A001273 | 2002-06-11 | ||
| IT2002MI001273A ITMI20021273A1 (en) | 2002-06-11 | 2002-06-11 | SYSTEM AND METHOD FOR THE AUTOMATIC DETECTION OF THE EXPIRATORY FLOW LIMITATION |
| PCT/EP2003/006119 WO2003103493A1 (en) | 2002-06-11 | 2003-06-10 | System and method for the automatic detection of the expiratory flow limitation |
| US11/002,368 US7325545B2 (en) | 2002-06-11 | 2004-12-02 | System and method for the automatic detection of the expiratory flow limitation |
| US12/013,626 US20080114261A1 (en) | 2002-06-11 | 2008-01-14 | System and method for the automatic detection of the expiratory flow limitation |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/002,368 Continuation US7325545B2 (en) | 2002-06-11 | 2004-12-02 | System and method for the automatic detection of the expiratory flow limitation |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US12/640,880 Continuation-In-Part US8128575B2 (en) | 2002-06-11 | 2009-12-17 | System and method for the automatic detection of the expiratory flow limitation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20080114261A1 true US20080114261A1 (en) | 2008-05-15 |
Family
ID=29727269
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/002,368 Expired - Lifetime US7325545B2 (en) | 2002-06-11 | 2004-12-02 | System and method for the automatic detection of the expiratory flow limitation |
| US12/013,626 Abandoned US20080114261A1 (en) | 2002-06-11 | 2008-01-14 | System and method for the automatic detection of the expiratory flow limitation |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US11/002,368 Expired - Lifetime US7325545B2 (en) | 2002-06-11 | 2004-12-02 | System and method for the automatic detection of the expiratory flow limitation |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US7325545B2 (en) |
| EP (2) | EP1551293B1 (en) |
| AU (1) | AU2003250829A1 (en) |
| DE (2) | DE60336774D1 (en) |
| IT (1) | ITMI20021273A1 (en) |
| WO (1) | WO2003103493A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090272381A1 (en) * | 2006-09-14 | 2009-11-05 | Raffaele Dellaca | Apparatus for respiratory support and non-invasive detection of alveolar derecruitment for patients suffering from respiratory failure |
| WO2011067698A3 (en) * | 2009-12-03 | 2011-09-01 | Koninklijke Philips Electronics N.V. | Method and apparatus for estimating respiratory impedance |
| US8973578B2 (en) | 2006-09-14 | 2015-03-10 | Politecnico Di Milano | Apparatus for respiratory support and non-invasive detection of alveolar derecruitment for patients suffering from respiratory failure |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20021273A1 (en) * | 2002-06-11 | 2003-12-11 | Milano Politecnico | SYSTEM AND METHOD FOR THE AUTOMATIC DETECTION OF THE EXPIRATORY FLOW LIMITATION |
| US8128575B2 (en) * | 2002-06-11 | 2012-03-06 | Politecnico Di Milano | System and method for the automatic detection of the expiratory flow limitation |
| EP1605999A1 (en) * | 2003-03-24 | 2005-12-21 | Weinmann Geräte für Medizin GmbH & Co. KG | Method and device for detecting leaks in respiratory gas supply systems |
| US7811274B2 (en) | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
| US7426929B2 (en) | 2003-05-20 | 2008-09-23 | Portaero, Inc. | Intra/extra-thoracic collateral ventilation bypass system and method |
| US7533667B2 (en) | 2003-05-29 | 2009-05-19 | Portaero, Inc. | Methods and devices to assist pulmonary decompression |
| US7252086B2 (en) | 2003-06-03 | 2007-08-07 | Cordis Corporation | Lung reduction system |
| US7377278B2 (en) | 2003-06-05 | 2008-05-27 | Portaero, Inc. | Intra-thoracic collateral ventilation bypass system and method |
| US7682332B2 (en) | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
| DE102004008057A1 (en) * | 2004-02-14 | 2005-09-01 | Ganshorn, Peter, Dipl.-Ing. (FH) | Device for the oscillometric analysis of the airway impedance |
| US8220460B2 (en) | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
| US7398782B2 (en) | 2004-11-19 | 2008-07-15 | Portaero, Inc. | Method for pulmonary drug delivery |
| US7824366B2 (en) | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
| US8104474B2 (en) | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
| US7406963B2 (en) | 2006-01-17 | 2008-08-05 | Portaero, Inc. | Variable resistance pulmonary ventilation bypass valve and method |
| DE102006011900A1 (en) * | 2006-03-15 | 2007-09-20 | Viasys Healthcare Gmbh | IOS measuring station and IOS measuring method |
| CN101511417A (en) | 2006-08-30 | 2009-08-19 | 雷斯梅德有限公司 | Distinguishing closed and open respiratory airway apneas by complex admittance values |
| US7931641B2 (en) | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
| US8163034B2 (en) | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
| US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
| CN101679366B (en) * | 2007-05-23 | 2013-08-07 | 默沙东公司 | Pyridyl piperidine orexin receptor antagonists |
| DE102007033860A1 (en) * | 2007-07-20 | 2009-01-22 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Test arrangement for testing sealing between mouthpiece of inhaler and user's lips has channel for secondary air around user's lips with second flow measurement device |
| WO2009105432A2 (en) | 2008-02-19 | 2009-08-27 | Portaero, Inc. | Devices and methods for delivery of a therapeutic agent through a pneumostoma |
| US8336540B2 (en) | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
| US8475389B2 (en) | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
| EP2349420B1 (en) | 2008-09-25 | 2016-08-31 | Covidien LP | Inversion-based feed-forward compensation of inspiratory trigger dynamics in medical ventilators |
| US8347881B2 (en) | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
| US8518053B2 (en) | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
| US20110213215A1 (en) * | 2010-02-26 | 2011-09-01 | Nellcor Puritan Bennett Llc | Spontaneous Breathing Trial Manager |
| EP2384697A1 (en) * | 2010-05-05 | 2011-11-09 | Universiteit Gent | Method and device for determining non-linear effects in the respiratory impedance |
| IT1401033B1 (en) | 2010-07-26 | 2013-07-12 | Milano Politecnico | SYSTEM AND METHOD FOR MEASURING THE MECHANICAL IMPEDANCE OF THE RESPIRATORY SYSTEM |
| JP6075972B2 (en) | 2012-05-30 | 2017-02-08 | 日本光電工業株式会社 | Respiratory state determination device |
| EP2934316B1 (en) | 2012-12-19 | 2022-09-07 | Koninklijke Philips N.V. | Detection of respiratory disorders |
| TW201446226A (en) * | 2013-06-04 | 2014-12-16 | jing-feng Liu | Artificial sounding device |
| US10064583B2 (en) * | 2013-08-07 | 2018-09-04 | Covidien Lp | Detection of expiratory airflow limitation in ventilated patient |
| US10492711B2 (en) * | 2015-05-31 | 2019-12-03 | Michael W. Wolfe | Handheld portable impulse oscillometer |
| JP7145885B2 (en) * | 2017-05-24 | 2022-10-03 | コーニンクレッカ フィリップス エヌ ヴェ | Expiratory flow limitation detection using pressure perturbation |
| IT201700093172A1 (en) * | 2017-08-11 | 2019-02-11 | Restech S R L | METHOD FOR THE EARLY IDENTIFICATION OF REPUTATION OF CHRONIC OBSTRUCTIVE BRONCOPNEUMOPATHY |
| US20190192795A1 (en) * | 2017-12-27 | 2019-06-27 | Koninklijke Philips N.V. | Expiratory flow limitation detection via flow resistor adjustment |
| IT202200018084A1 (en) | 2022-09-02 | 2024-03-02 | Restech S R L | System and method for measuring mechanical impedance of the respiratory system |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4051843A (en) * | 1975-02-26 | 1977-10-04 | Siemens Aktiengesellschaft | Apparatus for the determination of the respiratory passageway resistance |
| US4197859A (en) * | 1977-03-30 | 1980-04-15 | Siemens Aktiengesellschaft | Apparatus for the determination of the respiratory passageway impedance |
| US5318038A (en) * | 1993-01-19 | 1994-06-07 | Trustees Of Boston University | Infant respiratory impedance measuring apparatus and methods using forced oscillations |
| US6142952A (en) * | 1997-10-29 | 2000-11-07 | The Board Of Regents, The University Of Texas System | Method and apparatus for detection and diagnosis of airway obstruction degree |
| US6435182B1 (en) * | 1999-03-24 | 2002-08-20 | Trustees Of Boston University | Enhanced ventilation waveform device |
| US20070185406A1 (en) * | 2006-02-07 | 2007-08-09 | Goldman Michael D | Systems and methods for processing pulmonary function data |
| US7325545B2 (en) * | 2002-06-11 | 2008-02-05 | Politecnico Di Milano | System and method for the automatic detection of the expiratory flow limitation |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3621833A (en) * | 1969-06-26 | 1971-11-23 | Robert Crane | Method and apparatus for automatically determining physiological parameters related to human breathing airway resistance and functional residual capacity |
| US4122839A (en) * | 1974-03-22 | 1978-10-31 | Siemens Aktiengesellschaft | Apparatus for the determination of respiratory passageway resistance |
| GB1599672A (en) * | 1977-12-09 | 1981-10-07 | Ireland Vitalograph | Apparatus for the determination of respiratory parameters |
| US4326416A (en) * | 1978-08-08 | 1982-04-27 | Cambridge Collaborative, Inc. | Acoustic pulse response measuring |
| DE3903857A1 (en) * | 1988-12-13 | 1990-06-21 | Schumann Klaus | IMPROVED DETERMINATION OF RESPIRATORY RESISTANCE AFTER THE OSCILLATION METHOD |
| US5513648A (en) * | 1994-02-28 | 1996-05-07 | Trustees Of Boston University | Partial body plethysmograph for measuring human respiratory system impedance |
| DE19716166A1 (en) * | 1997-04-18 | 1998-10-22 | Meier Bernd Horst Dr | Artificial respiration machine |
| US6066101A (en) * | 1998-04-20 | 2000-05-23 | University Of Maryland | Airflow perturbation device and method for measuring respiratory resistance |
| US6257234B1 (en) * | 1998-08-21 | 2001-07-10 | Respironics, Inc. | Apparatus and method for determining respiratory mechanics of a patient and for controlling a ventilator based thereon |
| US6473640B1 (en) * | 1999-01-25 | 2002-10-29 | Jay Erlebacher | Implantable device and method for long-term detection and monitoring of congestive heart failure |
| US6340025B1 (en) * | 1999-10-04 | 2002-01-22 | American Biosystems, Inc. | Airway treatment apparatus with airflow enhancement |
| DE10014427A1 (en) * | 2000-03-24 | 2001-10-04 | Weinmann G Geraete Med | Method for controlling a ventilator and device for monitoring |
| US6377845B1 (en) * | 2000-07-25 | 2002-04-23 | Datascope Investment Corp. | Method and device for sensing impedance respiration |
-
2002
- 2002-06-11 IT IT2002MI001273A patent/ITMI20021273A1/en unknown
-
2003
- 2003-06-10 EP EP03757061A patent/EP1551293B1/en not_active Expired - Lifetime
- 2003-06-10 WO PCT/EP2003/006119 patent/WO2003103493A1/en not_active Ceased
- 2003-06-10 AU AU2003250829A patent/AU2003250829A1/en not_active Abandoned
- 2003-06-10 DE DE60336774T patent/DE60336774D1/en not_active Expired - Lifetime
- 2003-06-10 DE DE60325987T patent/DE60325987D1/en not_active Expired - Lifetime
- 2003-06-10 EP EP08022184A patent/EP2044883B1/en not_active Expired - Lifetime
-
2004
- 2004-12-02 US US11/002,368 patent/US7325545B2/en not_active Expired - Lifetime
-
2008
- 2008-01-14 US US12/013,626 patent/US20080114261A1/en not_active Abandoned
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4051843A (en) * | 1975-02-26 | 1977-10-04 | Siemens Aktiengesellschaft | Apparatus for the determination of the respiratory passageway resistance |
| US4197859A (en) * | 1977-03-30 | 1980-04-15 | Siemens Aktiengesellschaft | Apparatus for the determination of the respiratory passageway impedance |
| US5318038A (en) * | 1993-01-19 | 1994-06-07 | Trustees Of Boston University | Infant respiratory impedance measuring apparatus and methods using forced oscillations |
| US6142952A (en) * | 1997-10-29 | 2000-11-07 | The Board Of Regents, The University Of Texas System | Method and apparatus for detection and diagnosis of airway obstruction degree |
| US6435182B1 (en) * | 1999-03-24 | 2002-08-20 | Trustees Of Boston University | Enhanced ventilation waveform device |
| US7325545B2 (en) * | 2002-06-11 | 2008-02-05 | Politecnico Di Milano | System and method for the automatic detection of the expiratory flow limitation |
| US20070185406A1 (en) * | 2006-02-07 | 2007-08-09 | Goldman Michael D | Systems and methods for processing pulmonary function data |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090272381A1 (en) * | 2006-09-14 | 2009-11-05 | Raffaele Dellaca | Apparatus for respiratory support and non-invasive detection of alveolar derecruitment for patients suffering from respiratory failure |
| US8689787B2 (en) * | 2006-09-14 | 2014-04-08 | Politecnico Di Milano | Apparatus for respiratory support and non-invasive detection of alveolar derecruitment for patients suffering from respiratory failure |
| US8973578B2 (en) | 2006-09-14 | 2015-03-10 | Politecnico Di Milano | Apparatus for respiratory support and non-invasive detection of alveolar derecruitment for patients suffering from respiratory failure |
| WO2011067698A3 (en) * | 2009-12-03 | 2011-09-01 | Koninklijke Philips Electronics N.V. | Method and apparatus for estimating respiratory impedance |
| CN102639056A (en) * | 2009-12-03 | 2012-08-15 | 皇家飞利浦电子股份有限公司 | Method and apparatus for estimating respiratory impedance |
| US20120289852A1 (en) * | 2009-12-03 | 2012-11-15 | Koninklijke Philips Electronics N.V. | Method and apparatus for estimating respiratory impedance |
| CN102639056B (en) * | 2009-12-03 | 2015-08-05 | 皇家飞利浦电子股份有限公司 | For estimating the method and apparatus of respiratory impedance |
| RU2606107C2 (en) * | 2009-12-03 | 2017-01-10 | Конинклейке Филипс Электроникс Н.В. | Method and device for assessment of respiratory impedance |
| US9649050B2 (en) * | 2009-12-03 | 2017-05-16 | Koninklijke Philips N.V. | Method and apparatus for estimating respiratory impedance |
Also Published As
| Publication number | Publication date |
|---|---|
| DE60336774D1 (en) | 2011-05-26 |
| EP2044883A2 (en) | 2009-04-08 |
| ITMI20021273A1 (en) | 2003-12-11 |
| US7325545B2 (en) | 2008-02-05 |
| EP1551293A1 (en) | 2005-07-13 |
| US20050178385A1 (en) | 2005-08-18 |
| DE60325987D1 (en) | 2009-03-12 |
| EP1551293B1 (en) | 2009-01-21 |
| WO2003103493A1 (en) | 2003-12-18 |
| EP2044883A3 (en) | 2009-05-13 |
| AU2003250829A1 (en) | 2003-12-22 |
| EP2044883B1 (en) | 2011-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7325545B2 (en) | System and method for the automatic detection of the expiratory flow limitation | |
| US8128575B2 (en) | System and method for the automatic detection of the expiratory flow limitation | |
| Cherniack | The physical properties of the lung in chronic obstructive pulmonary emphysema | |
| Gibson | Clinical Tests of Respiratory Function 3rd Edition | |
| Yadollahi et al. | A robust method for estimating respiratory flow using tracheal sounds entropy | |
| Ritz et al. | Guidelines for mechanical lung function measurements in psychophysiology | |
| Desai et al. | Impulse oscillometry | |
| US20070282212A1 (en) | Non-Invasive Monitoring of Respiratory Rate, Heart Rate and Apnea | |
| US8100836B2 (en) | Augmented RIC model of respiratory systems | |
| WO2003022149A9 (en) | System for measuring respiratory function | |
| Mazurek et al. | Specificity and sensitivity of respiratory impedance in assessing reversibility of airway obstruction in children | |
| ENGSTRÖM et al. | Respiratory Studies in Children. IX: Relationships between Mechanical Properties of the Lungs, Lung Volumes and Ventilatory Capacity in Healthy Children 7–15 Years of Age 1 | |
| Jackson et al. | Density dependence of respiratory system impedances between 5 and 320 Hz in humans | |
| Truwit et al. | Evaluation of thoracic mechanics in the ventilated patient part 1: Primary measurements | |
| Brown et al. | Influence of abdominal gas on the Boyle's law determination of thoracic gas volume | |
| Tsai et al. | Respiratory parameter estimation using forced oscillatory impedance data | |
| Kano et al. | Determination of peak expiratory flow | |
| Reisch et al. | Early detection of upper airway obstructions by analysis of acoustical respiratory input impedance | |
| Wang et al. | Contribution of diaphragmatic-abdominal displacement to ventilation in supine man. | |
| Reinhold et al. | Comparative evaluation of impulse oscillometry and a monofrequency forced oscillation technique in clinically healthy calves undergoing bronchochallenges | |
| Sobol | Tests of Ventilatory Function Not Requiring Maximal Subject Effort: II. The Measurement of Total Respiratory Impedance | |
| Peslin et al. | Partitioning of airway and respiratory tissue mechanical impedances by body plethysmography | |
| Ntima et al. | Physiology and conduct of pulmonary function tests | |
| Pochekutova et al. | Duration of tracheal sound recorded during forced expiration: from a model to establishing standards | |
| Liu et al. | Universal Modeling Method of Electrical Impedance Response During Respiration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |